Soft Tissue Dermal Fillers May Be Dangerous, FDA Warns

First Posted: May 29, 2015 03:33 PM EDT

The U.S. Food and Drug Administration (FDA) is warning health care providers and consumers about potential dangers associated with soft tissue dermal fillers. Research showed that they can accidentally be injected into blood vessels located anywhere on the face, resulting in serious harm.

Researchers found that the most common place for problems to occur was between the nose and the eyebrows, on the forehead and around the eyes, in general. Now, it is a required that the makers of facial fillers update their labeling to include additional warnings about the risk of accidental injection into blood vessels.

While the current labeling includes some information regarding potential risks, the FDA said they believed that additional information should be included to better inform anyone using the product.

These dermal fillers are injected directly into the treatment area, helping to reduce the appearance of wrinkles and creating a smoother, fuller appearance.

Makers of dermal fillers include Valeant Pharmaceuticals International Inc and Allergan Inc, which was bought by Actavis Plc in March.

High Demand for Wrinkle Free America Drives Use of Botox, Fillers
FDA Allows Botox Cosmetic For Crow's Feet

For more great science stories and general news, please visit our sister site, Headlines and Global News (HNGN).

See Now: NASA's Juno Spacecraft's Rendezvous With Jupiter's Mammoth Cyclone

TagsHealth, Human, FDA, Blood, Blood Vessels, Face, Risk, Mortality